Auris Nasus Larynx provides the opportunity for rapid, carefully reviewed publications concerning the fundamental and clinical aspects of otorhinolaryngology and related fields. This includes otology, neurotology, bronchoesophagology, laryngology, rhinology, allergology, head and neck medicine and oncologic surgery, maxillofacial and plastic surgery, audiology, speech science and communication disorders.
Types of paper
Original papers and original case reports can be submitted. Thorough and detailed reviews on recent developments and Letters to the Editor commenting on papers or any aspect of the Journal are welcomed.
Original papers should report the results of original research, and the material should not have been previously published elsewhere, except in preliminary form. Manuscripts should be as concise and to the point as possible. Please condense your manuscript as much as possible. It is recommended that papers should in general not exceed 10 printed pages.Manuscript reporting randomized controlled trials should be submitted with CONSORT checklist accompanied by a flow diagram that illustrates the progress of patients through the trial, including recruitment, enrollment, randomization, withdrawal and completion, and a detailed description of the randomization procedure. The CONSORT checklist and template of flow diagram can be found on http://www.consort-statement.org/.Case reports should describe truly unique and/or educationally valuable cases, which provide benefits for future patients. Text should be limited to 1800 words (6 double-spaced typewritten pages) including an abstract, with no more than 15 references and a maximum of 4 figures/tables. An abstract for case reports should not exceed 200 words and should not have a structured format.
Online Submission of Manuscripts http://ees.elsevier.com/anl.Submission and peer review of all papers is now conducted entirely online using the dedicated site at http://ees.elsevier.com/anl
Authors are required to register upon using the system for the first time. Authors are guided stepwise through the entire process, and are kept abreast of the progress of their paper at each stage.The system creates a PDF version of the submitted manuscript for peer review, revision and proofing. All correspondence, including the Editor's decision and request for revisions, is conducted by e-mail.
Further Information and Support
Authors requesting further information on online submission are strongly encouraged to view an online tutorial, at http://ees.elsevier.com/anl or visit our customer support site at http://support.elsevier.com
Submission of an article is understood to imply that the article is original and is not being considered for publication elsewhere. Upon acceptance of the article by the journal, the author(s) will be asked to transfer the copyright of the article to the publisher. This transfer will ensure the widest possible dissemination of information.Multiple Authorship
On submission, all authors of the paper listed should sign a letter in which they state that they all have participated sufficiently in the conception and design of the work, in the analysis of the data and in writing the manuscript to take public responsibility for it.Clinical trial
Any clinical trial must be registered in a publicly accessible database. Auris Nasus Larynx requires that authors provide the name of the trial's registry and their clinical trial registration number at the end of the abstract. This is valid for submission on or after February 21, 2014. Auris Nasus Larynx follows recommendations of the International Committee of Medical Journal Editors (ICMJE)(http://www.icmje.org/).Purely observational studies will not require registration.
Any investigation on human subjects must be in accordance with the Code of Ethics of the World Medical Association (Helsinki Declaration). Auris Nasus Larynx requires authors to state in the Method section that the protocol of the investigation has been approved by the Institutional Review Board, and that the investigators have obtained written informed consent from each participant or each participant's guardian. A patient's anonymity needs to be preserved. An eye bar should be used for photographs. For experiments involving animals, authors must state in the Method section that the protocol has been approved by the Institutional Review Board, and that the animals were handled in accordance with the guidelines prepared by the Animal Use Committee of the institution.
Find out how you can share your research published in Elsevier journals.
• Articles are freely available to both subscribers and the wider public with permitted reuse.
• An open access publication fee is payable by authors or on their behalf, e.g. by their research funder or institution.
• Articles are made available to subscribers as well as developing countries and patient groups through our universal access programs.
• No open access publication fee payable by authors.
Regardless of how you choose to publish your article, the journal will apply the same peer review criteria and acceptance standards.For open access articles, permitted third party (re)use is defined by the following Creative Commons user licenses:
Creative Commons Attribution (CC BY)
Lets others distribute and copy the article, create extracts, abstracts, and other revised versions, adaptations or derivative works of or from an article (such as a translation), include in a collective work (such as an anthology), text or data mine the article, even for commercial purposes, as long as they credit the author(s), do not represent the author as endorsing their adaptation of the article, and do not modify the article in such a way as to damage the author's honor or reputation.
The open access fee for this journal is $3,000, excluding taxes. Learn more about Elsevier's pricing policy.
Preparation of Manuscripts
Authors are asked to bear in mind the following additional points before entering the submission process. Ensure that the letter "l" and digit "1" (also letter "O" and digit "0") have been used properly, and structure your article (tabs, indents, etc.) consistently. Manuscripts should be written in English. Authors whose native language is not English are strongly advised to have their manuscripts checked by an Englishspeaking colleague prior to submission.
Most text formats can be accommodated, but Microsoft Word is preferable. Manuscripts should in general be divided into the following components: title, authors' names and affiliations, abstract, keywords, text (introduction, materials and methods, results, discussion, conclusion, acknowledgments, conflict of interest), references, tables, figure legends, figures. Number pages consecutively.
The title page should include (1) a concise but informative title, (2) authors' names, affiliations and full postal addresses, (3) name, telephone number and e-mail address of the author handling correspondence and proofs.Abstract
An abstract of your manuscript summarizing the content, at a maximum of 400 words, should be provided as a separate submission item. It should be informative, not merely descriptive, and it must be composed by four divisions: (1) Objective should concisely describe the hypothesis, problem and/or purpose of the study; (2) Methods should include basic procedures and materials, and observational and analytical methods; (3) Results should describe major findings and statistical significance, if possible by all means; and (4) Conclusion must very clearly and concisely state the principal conclusion(s) of the study. Reviews and Case reports need not follow these instructions. Abstracts for Case reports should not exceed 200 words. Conflict of Interest
All authors are required to declare any financial support or relationship that may pose a conflict of interest as a "Disclosure Statement" between the Acknowledgements and References sections.
Figures of good quality should be submitted online as a separate file. For preparing figure files, please refer to instructions at http://www.elsevier.com/artworkinstructions. Minimum resolutions for line drawings should be 600 dpi and photographs 300 dpi.
Illustrations should be designed with the format of the page of the journal in mind. Illustrations and lettering should be of such a size as to allow a photographic reduction of 50% without becoming illegible. Explanations should preferably be given in the typewritten legend. Drawn text in the illustrations should be kept to a minimum.If scales are required, use bar scales on the illustration itself instead of numerical magnification factors.
Each illustration should have a legend. The legends to all illustrations should be typed together on a separate sheet at the end of the manuscript.Colour illustrations can only be included, if the cost of reproduction is paid for by the author or a sponsor.
Permission to reproduce illustrations should always be obtained before submission and details included with the captions.For detailed instructions on the preparation of electronic artwork, consult Elsevier's Author Gateway at http://authors.elsevier.com
Tables should be submitted online as a separate file, bear a concise title, and be numbered with Arabic numerals. Tables should be cited in the text. Column headings should be brief, but sufficiently explanatory. Standard abbreviations of units of measurement should be added between parentheses. Vertical lines should not be used to separate columns.
This journal encourages you to cite underlying or relevant datasets in your manuscript by citing them in your text and including a data reference in your Reference List. Data references should include the following elements: author name(s), dataset title, data repository, version (where available), year, and global persistent identifier. Add [dataset] immediately before the reference so we can properly identify it as a data reference. The [dataset] identifier will not appear in your published article.
1. All publications cited in the text should be presented in a list of references following the text of the manuscript. The manuscript should be carefully checked to ensure that the spellings of authors' names are exactly the same in the text and in the list of references. Authors are responsible for the accuracy and completeness of their references and for correct text citation.
Examples: Froehlich P, Seid AB, Morgon A. Contrasting strategic approaches to the management of subglottic hemangiomas. Int J Pediatr Otorhinolaryngol 1996;36:137-46.
 Marcus R, Couston AM. Water-soluble vitamins: the vitamin B complex and ascorbic acid. In: Gilman AG, Rall TW, Nies AS, Taylor P, editors. Goodman and Gilman's The pharmacological basis of therapeutics. 8th ed. New York: Pergamon Press; 1990. p. 1530-52.Oguro M, Imahiro S, Saito S, Nakashizuka T. Mortality data for Japanese oak wilt disease and surrounding forest compositions, Mendeley Data, v1; 2015. http://dx.doi.org/10.17632/xwj98nb39r.1.
3. This journal should be cited as Auris Nasus Larynx.4. Manuscripts accepted for publication not yet published should be referred to as "in press." Manuscripts submitted but not yet accepted should be referred to as "unpublished observation.
Supplementary and Multimedia Data
Elsevier accepts electronic supplementary and multimedia data to support and enhance your scientific research. Supplementary files offer the author additional possibilities to publish supporting applications, movies, animation sequences, high-resolution images, background datasets, sound clips and more. Supplementary files supplied will be published online alongside the electronic version of your article in Elsevier Web products, including ScienceDirect: http://www.sciencedirect.com. In order to ensure that your submitted material is directly usable, please ensure that data are provided in one of our recommended file formats. Authors should submit the material in electronic format together with the article and supply a concise and descriptive caption for each file. Video files: please supply 'stills' with your files: you can choose any frame from the video or make a separate image. These will be used instead of standard icons and will personalize the link to your supplementary information. For more detailed instructions please visit our artwork instruction pages at http://www.elsevier.com/artworkinstructions.
Corresponding authors will receive an e-mail with a link to our Proof Central system, allowing annotation and correction of proofs online. The environment is similar to MS Word: in addition to editing text, you can also comment on figures/tables and answer questions from the Copy Editor. Web-based proofing provides a faster and less error-prone process by allowing you to directly type your corrections, eliminating the potential introduction of errors. If preferred, you can still choose to annotate and upload your edits on the PDF version. All instructions for proofing will be given in the e-mail we send to authors, including alternative methods to the online version and PDF. We will do everything possible to get your article published quickly and accurately - please upload all of your corrections within 48 hours. It is important to ensure that all corrections are sent back to us in one communication. Please check carefully before replying, as inclusion of any subsequent corrections cannot be guaranteed. Proofreading is solely your responsibility. Note that Elsevier may proceed with the publication of your article if no response is received.
The corresponding author, at no cost, will be provided with a personalized link providing 50 days free access to the final published version of the article on ScienceDirect. This link can also be used for sharing via email and social networks. For an extra charge, paper offprints can be ordered via the offprint order form which is sent once the article is accepted for publication. Both corresponding and co-authors may order offprints at any time via Elsevier's WebShop (http://webshop.elsevier.com/myarticleservices/offprints). Authors requiring printed copies of multiple articles may use Elsevier WebShop's 'Create Your Own Book' service to collate multiple articles within a single cover (http://webshop.elsevier.com/myarticleservices/booklets).
As an author you (or your employer or institution) retain certain rights; for details you are referred to: http://www.elsevier.com/authorsrights.
Auris Nasus Larynx has no page charges